Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
31 studies found for:    "Meniere disease"
Show Display Options
RSS Create an RSS feed from your search for:
"Meniere disease"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Study of OTO-104 in Subjects With Unilateral Meniere's Disease
Condition: Meniere's Disease
Interventions: Drug: OTO-104;   Drug: Placebo
2 Active, not recruiting Study of OTO-104 in Subjects With Unilateral Meniere's Disease
Condition: Meniere's Disease
Interventions: Drug: OTO-104;   Drug: Placebo
3 Completed Effects of Betaserc on Vestibular Compensation in Patients Suffering From Disabling Meniere's Disease and Having Undergone Vestibular Neurotomy
Condition: Meniere's Disease
Intervention: Drug: Betahistine 24 mg bid (Betaserc)
4 Completed
Has Results
Transtympanic Gentamicin vs. Steroids in Refractory Meniere's Disease
Condition: Meniere's Disease
Interventions: Drug: Methylprednisolone;   Drug: Gentamicin
5 Completed
Has Results
Clinical Trial of Traditional Chinese Diaoshi Jifa Therapy of Meniere's Disease
Condition: Meniere's Disease
Interventions: Other: Diaoshi Jifa therapy plus the Western medical treatment.;   Other: drug
6 Active, not recruiting Latanoprost for the Treatment of Menière's Disease
Condition: Menière's Disease
Interventions: Drug: Latanoprost;   Other: Placebo
7 Completed Vasopressin and V2 Receptor in Meniere's Disease
Condition: Meniere Disease
Intervention: Genetic: vasopressin, V2 receptor and cyclic AMP
8 Completed OTO-104 for Meniere's Disease
Condition: Meniere's Disease
Interventions: Drug: OTO-104 (steroid) 3 mg;   Drug: Placebo;   Drug: OTO-104 (steroid) 12 mg
9 Completed Effects of Endolymphatic Sac Drainage With Steroids for Meniere’s Disease
Condition: Meniere's Disease
Intervention: Procedure: endolymphatic sac drainage with steroids
10 Terminated Famvir for Treatment of Hearing in Unilateral Meniere's Disease
Condition: Meniere's Disease
Interventions: Drug: Famciclovir;   Drug: Placebo
11 Completed Sildenafil For Meniere's Disease
Condition: Meniere's Disease
Intervention: Drug: Sildenafil
12 Completed OTO-104 for the Treatment of Meniere's Disease
Condition: Meniere's Disease
Interventions: Drug: OTO-104;   Drug: Placebo
13 Withdrawn Unilateral Meniere Disease: Can Double Dose Gadolinium and Delayed Imaging Make the Diagnosis?
Condition: Meniere Disease
Intervention: Drug: Gadopentetate dimeglumine
14 Completed Efficacy of Local Overpressure Treatment for Meniere's Disease
Condition: Meniere's Disease
Interventions: Device: Meniett(C) device by MedTronic;   Device: placebo treatment
15 Enrolling by invitation Study to Evaluate SPI-1005 in Adults With Meniere's Disease
Condition: Meniere's Disease
Intervention: Drug: SPI-1005
16 Active, not recruiting Open Label Study of OTO-104 in Subjects With Meniere's Disease
Condition: Meniere's Disease
Intervention: Drug: OTO-104
17 Enrolling by invitation A 6-Month Extension Study of OTO-104 in Meniere's Disease
Condition: Meniere's Disease
Intervention: Drug: OTO-104
18 Enrolling by invitation A 6-Month Extension Study of OTO-104 in Meniere's Disease
Condition: Meniere's Disease
Intervention: Drug: OTO-104
19 Recruiting Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease
Condition: Meniere's Disease
Intervention: Drug: Gadolinium
20 Completed A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom
Condition: Meniere's Disease
Interventions: Drug: OTO-104;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.